Key result
Chemoreceptor deactivation by hyperoxia significantly reduced cardiac sympathetic nerve activity (75 vs 90 bursts per 100 heart beats, P<0.05) in sheep with mild heart failure.
Why the study?
Does chemoreceptor deactivation by hyperoxia reduce cardiac sympathetic nerve activity in mild ovine heart failure?
Does chemoreceptor deactivation by hyperoxia reduce cardiac sympathetic nerve activity in mild ovine heart failure?
Absolute Event Rate: 75% vs 90%
p-value: p=< 0.05
Deactivation of peripheral chemoreceptors by hyperoxia reduces elevated cardiac sympathetic nerve activity and heart rate in a sheep model of mild heart failure.
Hyperoxia may attenuate sympathetic drive in mild ovine HF; leaves open chemoreflex targeting in human patients.
New Findings What is the central question of this study? What is the role of the peripheral chemoreflex in driving the increased levels of cardiac sympathetic nerve activity in heart failure? What is the main finding and its importance? We show that chemoreceptor deactivation by hyperoxia significantly decreased the elevated levels of cardiac sympathetic nerve activity and heart rate in mild ovine heart failure. Our findings suggest that interventional strategies that reduce chemoreceptor afferent activity in heart failure will reduce the elevated level of cardiac sympathetic drive and its associated detrimental effects. Heart failure (HF) is associated with a large increase in cardiac sympathetic nerve activity (CSNA), which has detrimental effects on the heart and promotes arrhythmias and sudden death. There is increasing evidence that arterial chemoreceptor activation plays an important role in stimulating renal sympathetic nerve activity (RSNA) and muscle sympathetic nerve activity in HF. Given that sympathetic nerve activity to individual organs is differentially controlled, we investigated whether tonic arterial chemoreceptor activation contributes to the increased CSNA in HF. We recorded CSNA and RSNA in conscious normal sheep and in sheep with mild HF induced by rapid ventricular pacing (ejection fraction <40%). Tonic arterial chemoreceptor function was evaluated by supplementing room air with 100% intranasal oxygen (2–3 l min −1 ) for 20 min, thereby deactivating chemoreceptors. The effects of hyperoxia on resting levels and baroreflex control of heart rate, CSNA and RSNA were determined. In HF, chemoreceptor deactivation induced by hyperoxia significantly reduced CSNA [90 ± 2 versus 75 ± 5 bursts (100 heart beats) −1 , P < 0.05, n = 10; room air versus hyperoxia] and heart rate (96 ± 4 versus 85 ± 4 beats min −1 , P < 0.001, n = 12). There was no change in RSNA burst incidence [93 ± 4 versus 92 ± 4 bursts (100 heart beats) −1 , n = 7], although due to the bradycardia the RSNA burst frequency was decreased (90 ± 8 versus 77 ± 7 bursts min −1 , P < 0.001). In normal sheep, chemoreceptor deactivation reduced heart rate without a significant effect on CSNA or RSNA. In summary, deactivation of peripheral chemoreceptors during HF reduced the elevated levels of CSNA, indicating that tonic arterial chemoreceptor activation plays a critical role in stimulating the elevated CSNA in HF.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2014) studied Mild ovine heart failure (n=12). Chemoreceptor deactivation by hyperoxia (100% intranasal oxygen) vs. Room air was evaluated on Cardiac sympathetic nerve activity (CSNA) (p=< 0.05). Chemoreceptor deactivation by hyperoxia significantly reduced cardiac sympathetic nerve activity (75 vs 90 bursts per 100 heart beats, P<0.05) in sheep with mild heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: